Lv3
284 积分 2022-10-24 加入
Valuing new drug R&D project under economic fluctuation, technical risks and subjective uncertainty
27天前
已关闭
Integrating scientific considerations into R&D project valuation
27天前
已完结
Chinese consensus on the diagnosis and management of herpes zoster （2022）
1个月前
已完结
Synchrotron Radiation: A Key Tool for Drug Discovery
2个月前
已完结
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective
2个月前
已完结
Deep whole-genome analysis of 494 hepatocellular carcinomas
3个月前
已完结
Real-time dynamic single-molecule protein sequencing on an integrated semiconductor device
4个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
4个月前
已完结
Atrasentan in Patients with IgA Nephropathy
4个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
4个月前
已完结
皖公网安备34019202002308
